Our Case Rerort

  • Ms. D    Age:57    Genotyping:2a   

    Ms. D from Hebei Province, with HCV-RNA quantity of 2.39E+05 IU/ml, could not tolerate IFN therapy due to her health condition. With our help, she went to India and took Sofosbuvir from Gilead in Fortis hospital in October. After two weeks of administration, .…

  • Mr.Y    Age:45    Genotyping:1b

    HCV-RNA quantity of Mr. Z from Anhui Province was 9.35E+05 IU/ml before his journey to India. After being aware of that Medembassy could get Sofosbuvir in India, he decided to join in Medembassy and accept treatment in India. He got Sofosbuvir from Gilead in India.…

  • Ms.J    Age:49    Genotyping:2a

    Ms. J from Liaoning Province, with HCV-RNA quantity of 4.50E+05 IU/ml before her journey to India, could not tolerate IFN therapy due to her health condition. With our help, she went to India and took Sofosbuvir from Gilead in Medanta hospital at the end of August.…


  • Mr.Y    Age:58    Genotyping:2a

    HCV-RNA quantity of Mr. Y from Heilongjiang Province was 11400IU/ml before his treatment. With our help, he went to India and took Sofosbuvir from Gilead in Fortis hospital at the end of August. After one month of administration, his HCV QUANT was negative.…

  • Mr.L    Age:28    Genotyping:1b

    HCV-RNA quantity of Mr. L from Hebei Province was 11400IU/ml on July 14th, before his treatment. With our help, he went to India and accepted treatment in Medanta hospital at the end of July. After returning with Sofosbuvir, he started the administration. …

  • Mr.Z    Age:36    Genotyping:2a

    HCV-RNA quantity of Mr. Z from Shanghai was 1.00E+07 IU/ml before his journey to India. With our help, he went to India and accepted treatment in Medanta hospital in July. After returning with Sofosbuvir, he started the administration. Two weeks later, 99.999% of his virus had been cleared.…